MicroRNA-30d-5p—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction

MicroRNA-30d-5p—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction

(1) Background and Objective: MicroRNAs (miRs) are biomarkers for assessing the extent of cardiac remodeling after myocardial infarction (MI) and important predictors of clinical outcome in heart failure. Overexpression of miR-30d-5p appears to have a cardioprotective effect. The aim of the present...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Elke Boxhammer, Vera Paar, Bernhard Wernly, Attila Kiss, Moritz Mirna, Achim Aigner, Eylem Acar, Simon Watzinger, Bruno K. Podesser, Roland Zauner, Verena Wally, Michael Ablinger, Matthias Hackl, Uta C. Hoppe, Michael Lichtenauer
Formato:	Artigo
Idioma:	English
Publicado em:	MDPI AG 2023-09-01
Colecção:	Cells
Assuntos:	cardioprotection ischemic cardiomyopathy miR-30d-5p myocardial infarction
Acesso em linha:	https://www.mdpi.com/2073-4409/12/19/2369

Registos relacionados

How Do Cardiovascular Biomarkers Behave in Patients with Severe Aortic Valve Stenosis with and without Echocardiographically Proven Pulmonary Hypertension?—A Retrospective Study of Biomarker Trends before and after Transcatheter Aortic Valve Replacement
Por: Elke Boxhammer, et al.
Publicado em: (2022-06-01)

MicroRNA Expression Profile Changes after Cardiopulmonary Bypass and Ischemia/Reperfusion-Injury in a Porcine Model of Cardioplegic Arrest
Por: Attila Kiss, et al.
Publicado em: (2020-04-01)

Treatment with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Does Not Affect Outcome in Patients with Acute Myocarditis or Myopericarditis
Por: Moritz Mirna, et al.
Publicado em: (2022-01-01)

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
Por: Ozan Demirel, et al.
Publicado em: (2023-05-01)

Normothermic Crystalloid Polarizing Cardioplegia Improves Systolic and Diastolic Function in a Porcine Model of Cardiopulmonary Bypass
Por: David Santer, et al.
Publicado em: (2024-12-01)

Conundrum of Classifying Subtypes of Pulmonary Hypertension—Introducing a Novel Approach to Classify “Borderline” Patients in a Population with Severe Aortic Stenosis Undergoing TAVI
Por: Elke Boxhammer, et al.
Publicado em: (2022-09-01)

Visual grading of valvular regurgitation is inferior to measurement – results from the VIAVA-study (VIsual Assessment of VAlvular Regurgitation)
Por: Ozan Demirel, et al.
Publicado em: (2024-11-01)

From Streptococcal Pharyngitis/Tonsillitis to Myocarditis: A Systematic Review
Por: Lukas Schmutzler, et al.
Publicado em: (2022-05-01)

Changes in Circulating Extracellular Vesicles in Patients with ST-Elevation Myocardial Infarction and Potential Effects of Remote Ischemic Conditioning—A Randomized Controlled Trial
Por: Paul M. Haller, et al.
Publicado em: (2020-07-01)

Nicotinamide: A cardioprotective form of Vitamin B3
Por: Du Qingyou
Publicado em: (2024-01-01)

Metabolic modulators in cardioprotection: A focus on trimetazidine
Por: Du Qingyou
Publicado em: (2024-01-01)

Isosteviol: A potential cardioprotective agent
Por: Jovanović Aleksandar
Publicado em: (2024-01-01)

Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
Por: Elke Boxhammer, et al.
Publicado em: (2022-03-01)

Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome
Por: Albert Topf, et al.
Publicado em: (2022-02-01)

Peptidomimetic 1-Benzyl-5-methyl-4-(<i>n</i>-octylamino)pyrimidin-2(1<i>H</i>)-one Showed Cardioprotection Effect in a Myocardial Ischemia (MI) Mouse Model
Por: Lena Trifonov, et al.
Publicado em: (2019-08-01)

The Cardioprotective Properties of Selected Nuts: Their Functional Ingredients and Molecular Mechanisms
Por: Beata Olas
Publicado em: (2024-01-01)

Anthracycline-induced cardiotoxicity – primary preventive options. An overview
Por: S. Slavcheva
Publicado em: (2024-05-01)

Tyrosol and Hydroxytyrosol: Their Role in Cardioprotection
Por: Cezary Guzowski, et al.
Publicado em: (2024-02-01)

Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest
Por: Richard Rezar, et al.
Publicado em: (2022-10-01)

Tei Index Is a Useful Adjunctive Tool in the Diagnostic Workup of Patients with Acute Myocarditis
Por: Moritz Mirna, et al.
Publicado em: (2022-08-01)

Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
Por: John Lee, et al.
Publicado em: (2024-12-01)

POTENTIAL OF THE MODERN ACE INHIBITOR ZOFENOPRIL IN CLINICAL PRACTICE: CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTIATHEROGENIC EFFECTS
Por: M. G. Bubnova
Publicado em: (2013-02-01)

The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
Por: Rony Abdi Syahputra, et al.
Publicado em: (2022-02-01)

Fabrication of Nanoformulation Containing Carvedilol and Silk Protein Sericin against Doxorubicin Induced Cardiac Damage in Rats
Por: Mohammad Shariq, et al.
Publicado em: (2023-04-01)

Promising Novel Biomarkers in Cardiovascular Diseases
Por: Brigitte Sipos, et al.
Publicado em: (2021-04-01)

The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events
Por: Albert Topf, et al.
Publicado em: (2021-10-01)

A review of cardioprotective effect of ginsenosides in chemotherapy-induced cardiotoxicity
Por: Hadi Zare-Zardini, et al.
Publicado em: (2024-12-01)

Cardiovascular Effects of Metformin
Por: B. T. Kurmanbekova, et al.
Publicado em: (2022-03-01)

ISCHEMIC PRECONDITIONING AND ITS CARDIOPROTECTIVE EFFECT IN POST-INTERVENTION CARDIAC REHABILITATION PROGRAMMES FOR PATIENTS WITH CORONARY HEART DISEASE
Por: E. S. Karpova, et al.
Publicado em: (2012-08-01)

PHARMACEUTICAL CORRECTION OF VASCULAR DISTURBANCES IN PATIENTS WITH ARTERIAL HYPERTENSION
Por: L. A. Khaisheva, et al.
Publicado em: (2010-10-01)

Antioxidant and Cardioprotective Effect of Coconut Water against Doxorubicin Induced Cardiomyopathy
Por: Nnodim Johnkennedy, et al.
Publicado em: (2013-07-01)

Comparative Cardioprotective Effectiveness: NOACs vs. Nattokinase—Bridging Basic Research to Clinical Findings
Por: Maja Muric, et al.
Publicado em: (2024-08-01)

A brief overview of cardioprotective signaling
Por: Jovanović Aleksandar
Publicado em: (2024-01-01)

A Comprehensive View on Drugs-Induced Cardiotoxicity and Its Prevention
Por: Abdulnaser Ali, et al.
Publicado em: (2024-03-01)

Progress on the role of melatonin in dilated cardiomyopathy
Por: LIU Jia, XU Kai, SHI Rui-zheng, ZHANG Guo-gang
Publicado em: (2022-07-01)

TRPV1 Contributes to Modulate the Nitric Oxide Pathway and Oxidative Stress in the Isolated and Perfused Rat Heart during Ischemia and Reperfusion
Por: Vicente Castrejón-Téllez, et al.
Publicado em: (2022-02-01)

Mitophagy Regulation Following Myocardial Infarction
Por: Annie Turkieh, et al.
Publicado em: (2022-01-01)

Selenium Organic Content Prediction in Jengkol (<i>Archidendron pauciflorum)</i> and Its Molecular Interaction with Cardioprotection Receptors PPAR-γ, NF-κB, and PI3K
Por: Ayu Shalihat, et al.
Publicado em: (2023-05-01)

Biochemical and histological evaluation of kidney, liver, and hematological indices in normal Wistar rats administered dietary formulations of roasted Sphenotylis stenocarpa seeds (Af-rican yam bean)
Por: Nene Hephzibah Chiaka-Onyemeze, et al.
Publicado em: (2025-01-01)

Biological evaluation of sophoridine by interaction with plasma transport protein and protective effects in cardiomyocytes
Por: Zheng Wu, et al.
Publicado em: (2024-12-01)